Gates Foundation grants $826K to Mass. biotech

04/4/2013 | American City Business Journals

The Bill & Melinda Gates Foundation, through its Grand Challenges Explorations initiative, awarded Tetragenetics a Phase II grant worth $826,000 to develop a more effective oral vaccine for malaria. The grant builds on a 2009 Phase I grant.

View Full Article in:

American City Business Journals

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
MGR POST MARKET STUDIES - 14000001LK
Abbott
Santa Ana, CA
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA
Associate Director, Regulatory Affairs - Promotional Review
Novo Nordisk
Princeton, NJ
Chief Executive Officer
UCare Minnesota
Minneapolis, MN
Program Coordinator/Lecturer for the Regulatory Science program
Johns Hopkins University
Washington, DC